106 related articles for article (PubMed ID: 15792872)
21. Localization of 4q35.2 to the nuclear periphery: is FSHD a nuclear envelope disease?
Masny PS; Bengtsson U; Chung SA; Martin JH; van Engelen B; van der Maarel SM; Winokur ST
Hum Mol Genet; 2004 Sep; 13(17):1857-71. PubMed ID: 15238509
[TBL] [Abstract][Full Text] [Related]
22. The Krüppel-like factor 15 as a molecular link between myogenic factors and a chromosome 4q transcriptional enhancer implicated in facioscapulohumeral dystrophy.
Dmitriev P; Petrov A; Ansseau E; Stankevicins L; Charron S; Kim E; Bos TJ; Robert T; Turki A; Coppée F; Belayew A; Lazar V; Carnac G; Laoudj D; Lipinski M; Vassetzky YS
J Biol Chem; 2011 Dec; 286(52):44620-31. PubMed ID: 21937448
[TBL] [Abstract][Full Text] [Related]
23. A functional role for 4qA/B in the structural rearrangement of the 4q35 region and in the regulation of FRG1 and ANT1 in facioscapulohumeral dystrophy.
Pirozhkova I; Petrov A; Dmitriev P; Laoudj D; Lipinski M; Vassetzky Y
PLoS One; 2008; 3(10):e3389. PubMed ID: 18852887
[TBL] [Abstract][Full Text] [Related]
24. Genomic analysis of facioscapulohumeral muscular dystrophy.
Clapp J; Bolland DJ; Hewitt JE
Brief Funct Genomic Proteomic; 2003 Oct; 2(3):213-23. PubMed ID: 15239924
[TBL] [Abstract][Full Text] [Related]
25. A functional SNP in the promoter region of TCOF1 is associated with reduced gene expression and YY1 DNA-protein interaction.
Masotti C; Armelin-Correa LM; Splendore A; Lin CJ; Barbosa A; Sogayar MC; Passos-Bueno MR
Gene; 2005 Oct; 359():44-52. PubMed ID: 16102917
[TBL] [Abstract][Full Text] [Related]
26. New SNPs in the coding and 5' flanking regions of porcine MYOD1 (MYF3) and MYF5 genes.
Urbański P; Kurył J
J Appl Genet; 2004; 45(3):325-9. PubMed ID: 15306724
[TBL] [Abstract][Full Text] [Related]
27. Facioscapulohumeral muscular dystrophy is uniquely associated with one of the two variants of the 4q subtelomere.
Lemmers RJ; de Kievit P; Sandkuijl L; Padberg GW; van Ommen GJ; Frants RR; van der Maarel SM
Nat Genet; 2002 Oct; 32(2):235-6. PubMed ID: 12355084
[TBL] [Abstract][Full Text] [Related]
28. [Facioscapulohumeral muscular dystrophy. The spectrum of clinical manifestations and molecular genetic changes].
Krasnianski M; Neudecker S; Eger K; Schulte-Mattler W; Zierz S
Nervenarzt; 2003 Feb; 74(2):151-8. PubMed ID: 12596016
[TBL] [Abstract][Full Text] [Related]
29. [Mechanism of translocation between chromosomes 4q and 10q in facioscapulohumeral muscular dystrophy].
Wang N; Wu ZY; Wang CD; Wang ZQ; Lin MT; Fang L; Murong SX
Zhonghua Yi Xue Za Zhi; 2003 Apr; 83(8):650-3. PubMed ID: 12887821
[TBL] [Abstract][Full Text] [Related]
30. Inappropriate gene activation in FSHD: a repressor complex binds a chromosomal repeat deleted in dystrophic muscle.
Gabellini D; Green MR; Tupler R
Cell; 2002 Aug; 110(3):339-48. PubMed ID: 12176321
[TBL] [Abstract][Full Text] [Related]
31. Typical facioscapulohumeral dystrophy phenotype in patients without FSHD 4q35 deletion.
Krasnianski M; Neudecker S; Eger K; Jakubiczka S; Zierz S
J Neurol; 2003 Sep; 250(9):1084-7. PubMed ID: 14504970
[TBL] [Abstract][Full Text] [Related]
32. Novel mitochondrial tRNA Leu(CUN) transition and D4Z4 partial deletion in a patient with a facioscapulohumeral phenotype.
Filosto M; Tonin P; Scarpelli M; Savio C; Greco F; Mancuso M; Vattemi G; Govoni V; Rizzuto N; Tupler R; Tomelleri G
Neuromuscul Disord; 2008 Mar; 18(3):204-9. PubMed ID: 18343111
[TBL] [Abstract][Full Text] [Related]
33. Evolutionary genomic remodelling of the human 4q subtelomere (4q35.2).
Bodega B; Cardone MF; Müller S; Neusser M; Orzan F; Rossi E; Battaglioli E; Marozzi A; Riva P; Rocchi M; Meneveri R; Ginelli E
BMC Evol Biol; 2007 Mar; 7():39. PubMed ID: 17359533
[TBL] [Abstract][Full Text] [Related]
34. [Progress in researches on the molecular genetics of facioscapulohumeral muscular dystrophy].
Su Q; Zhang C
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Oct; 18(5):398-401. PubMed ID: 11592052
[TBL] [Abstract][Full Text] [Related]
35. Genomic analysis of human chromosome 10q and 4q telomeres suggests a common origin.
van Geel M; Dickson MC; Beck AF; Bolland DJ; Frants RR; van der Maarel SM; de Jong PJ; Hewitt JE
Genomics; 2002 Feb; 79(2):210-7. PubMed ID: 11829491
[TBL] [Abstract][Full Text] [Related]
36. Atypical phenotypes in patients with facioscapulohumeral muscular dystrophy 4q35 deletion.
Krasnianski M; Eger K; Neudecker S; Jakubiczka S; Zierz S
Arch Neurol; 2003 Oct; 60(10):1421-5. PubMed ID: 14568813
[TBL] [Abstract][Full Text] [Related]
37. Early-onset facioscapulohumeral muscular dystrophy type 1 with some atypical features.
Dorobek M; van der Maarel SM; Lemmers RJ; Ryniewicz B; Kabzińska D; Frants RR; Gawel M; Walecki J; Hausmanowa-Petrusewicz I
J Child Neurol; 2015 Apr; 30(5):580-7. PubMed ID: 24717985
[TBL] [Abstract][Full Text] [Related]
38. A polymorphic dinucleotide repeat in the rat nucleolin gene forms Z-DNA and inhibits promoter activity.
Rothenburg S; Koch-Nolte F; Rich A; Haag F
Proc Natl Acad Sci U S A; 2001 Jul; 98(16):8985-90. PubMed ID: 11447254
[TBL] [Abstract][Full Text] [Related]
39. Somatic mosaicism in FSHD often goes undetected.
Lemmers RJ; van der Wielen MJ; Bakker E; Padberg GW; Frants RR; van der Maarel SM
Ann Neurol; 2004 Jun; 55(6):845-50. PubMed ID: 15174019
[TBL] [Abstract][Full Text] [Related]
40. [First facioscapulohumeral muscular dystrophy prenatal diagnosis in a Bulgarian family].
Buzhkov BTs; Vŭzharova R; Dimitrova V; Dimova I; Tŭrnev I; van der Wielen M; van der Maarel S; Bakker B
Akush Ginekol (Sofiia); 2005; 44(2):30-3. PubMed ID: 15853025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
